%0 Journal Article
%T Potential of oncolytic viruses in the treatment of multiple myeloma
%A Eric Bartee
%J Archive of "Oncolytic Virotherapy".
%D 2017
%R 10.2147/OV.S136644
%X Multiple myeloma (MM) is a clonal malignancy of plasma cells that is newly diagnosed in ~30,000 patients in the US each year. While recently developed therapies have improved the prognosis for MM patients, relapse rates remain unacceptably high. To overcome this challenge, researchers have begun to investigate the therapeutic potential of oncolytic viruses as a novel treatment option for MM. Preclinical work with these viruses has demonstrated that their infection can be highly specific for MM cells and results in impressive therapeutic efficacy in a variety of preclinical models. This has led to the recent initiation of several human trials. This review summarizes the current state of oncolytic therapy as a therapeutic option for MM and highlights a variety of areas that need to be addressed as the field moves forward
%K oncolytic virotherapy
%K multiple myeloma
%K review
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826297/